Literature DB >> 26672968

An Update on Helicobacter pylori as the Cause of Gastric Cancer.

Wei Zhang1, Hong Lu1, David Y Graham2.   

Abstract

BACKGROUND: Gastric cancer is the second most common cause of cancer deaths worldwide. The vast majority of gastric cancers are inflammation-related cancers caused by infection with Helicobacter pylori. H. pylori-induced oxidative stress damages DNA, resulting in genetic instability. In addition, H. pylori itself can cause DNA damage and epigenetic changes that trigger genetic instability and neoplastic transformation.
SUMMARY: H. pylori strain-specific components act in combination with host factors and environmental and dietary factors to greatly enhance the inflammatory response and thus the cancer risk. Variations in several key factors, such as the cag pathogenicity island and the VacA protein, can trigger a greater inflammatory response in host cells. Genetic polymorphisms in the host such as in the IL-1β gene, and chromosomes 9p21.3 and 10q23 also play a contributing role. Finally, diet is a major external factor that modulates the risk of gastric cancer. KEY MESSAGE: The majority of gastric cancers are inflammation-related cancers caused by infection with H. pylori. Eradication of H. pylori is important for the prevention and treatment of gastric cancer. PRACTICAL IMPLICATIONS: H. pylori eradication results in healing of gastritis and prevention of further H. pylori-induced genetic damage. Eradication of H. pylori prior to development of atrophic gastritis can prevent the development of gastric cancer. Japan has undertaken a nationwide program to identify and eliminate H. pylori, along with surveillance for those who underwent H. pylori eradication too late to eliminate cancer risk. Population-wide eradication of H. pylori will result in gastric cancer becoming a vanishingly rare disease.

Entities:  

Keywords:  Gastric cancer; Helicobacter pylori; Pathogenesis; Virulence factors

Year:  2014        PMID: 26672968      PMCID: PMC4645582          DOI: 10.1159/000365310

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  80 in total

1.  Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships.

Authors:  Yoshio Yamaoka; Rita Reddy; David Y Graham
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

2.  Erythrocyte Lewis (A+B-) host phenotype is a factor with familial clustering for increased risk of Helicobacter pylori-related non-cardiac gastric cancer.

Authors:  Ming-Jen Sheu; Hsiao-Bai Yang; Bor-Shyang Sheu; Hsiu-Chi Cheng; Ching-Yih Lin; Jiunn-Jong Wu
Journal:  J Gastroenterol Hepatol       Date:  2006-06       Impact factor: 4.029

3.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

4.  Role of Helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization.

Authors:  Lyudmila Boyanova
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

Review 5.  Tyrosine-phosphorylated bacterial effector proteins: the enemies within.

Authors:  Steffen Backert; Matthias Selbach
Journal:  Trends Microbiol       Date:  2005-10       Impact factor: 17.079

6.  The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice.

Authors:  K A Eaton; M Mefford; T Thevenot
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

Review 7.  Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis.

Authors:  Caiyun He; Moye Chen; Jingwei Liu; Yuan Yuan
Journal:  Mutat Res Rev Mutat Res       Date:  2013-09-25       Impact factor: 5.657

8.  Helicobacter pylori strain types and risk of gastric cancer: a case-control study.

Authors:  H Enroth; W Kraaz; L Engstrand; O Nyrén; T Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-09       Impact factor: 4.254

Review 9.  Oncogenic mechanisms of the Helicobacter pylori CagA protein.

Authors:  Masanori Hatakeyama
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

10.  Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice.

Authors:  Peter J Jenks; Anthony H T Jeremy; Philip A Robinson; Marjorie M Walker; Jean E Crabtree
Journal:  J Pathol       Date:  2003-12       Impact factor: 7.996

View more
  11 in total

1.  New observations regarding Helicobacter pylori and gastric cancer in Mongolia.

Authors:  Boldbaatar Gantuya; Dashdorj Bolor; Khasag Oyuntsetseg; Yansan Erdene-Ochir; Ruvjir Sanduijav; Duger Davaadorj; Tegshee Tserentogtokh; Dashdorj Azzaya; Tomohisa Uchida; Takeshi Matsuhisa; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2018-06-08       Impact factor: 5.753

2.  Cancer Incidence Characteristic Evolution Based on the National Cancer Registry in Taiwan.

Authors:  Yu-Ching Huang; Yu-Hung Chen
Journal:  J Oncol       Date:  2020-07-22       Impact factor: 4.375

3.  Increased Risk to Develop Hypertension and Carotid Plaques in Patients with Long-Lasting Helicobacter pylori Gastritis.

Authors:  Maria Pina Dore; Pier Sergio Saba; Giulia Tomassini; Caterina Niolu; Marco Monaco; Giovanni Mario Pes
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

Review 4.  Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases.

Authors:  Bidisha Paul; Stephen Barnes; Wendy Demark-Wahnefried; Casey Morrow; Carolina Salvador; Christine Skibola; Trygve O Tollefsbol
Journal:  Clin Epigenetics       Date:  2015-10-16       Impact factor: 6.551

5.  Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.

Authors:  Maria Pina Dore; Alice Cipolli; Matteo Walter Ruggiu; Alessandra Manca; Gabrio Bassotti; Giovanni Mario Pes
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

6.  CagA orchestrates eEF1A1 and PKCδ to induce interleukin-6 expression in Helicobacter pylori-infected gastric epithelial cells.

Authors:  Shaohan Xu; Xiaoqian Wu; Xiaoyan Zhang; Chu Chen; Hao Chen; Feifei She
Journal:  Gut Pathog       Date:  2020-07-03       Impact factor: 4.181

7.  Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer.

Authors:  Zheng Chen; Tianling Hu; Shoumin Zhu; Kenichi Mukaisho; Wael El-Rifai; Dun-Fa Peng
Journal:  Oncotarget       Date:  2017-04-29

8.  Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer.

Authors:  Yeganeh Talebkhan; Mohsen Doozbakhshan; Samaneh Saberi; Maryam Esmaeili; Najmeh Karami; Nazanin Mohajerani; Afshin Abdirad; Mahmoud Eshagh Hosseini; Azin Nahvijou; Mohammad Ali Mohagheghi; Marjan Mohammadi
Journal:  Iran Biomed J       Date:  2016-09-28

9.  Suppressed Helicobacter pylori-associated gastric tumorigenesis in Fat-1 transgenic mice producing endogenous ω-3 polyunsaturated fatty acids.

Authors:  Young-Min Han; Kyung-Jo Kim; Migyeung Jeong; Jong-Min Park; Eun-Jin Go; Jing X Kang; Sung Pyo Hong; Ki Baik Hahm
Journal:  Oncotarget       Date:  2016-10-11

Review 10.  The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer.

Authors:  Sheetal Parida; Dipali Sharma
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-11       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.